High materiality8/10
Biogen price target raised to $270 from $240 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises BIIB target to $270 (from $240); current price about $223.25.
- UBS raises BIIB target to $270; price ~$223.25.
Key facts
- 01
Target: $270
- 02
Posted price: $223.25
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.